Archive for September 2017

Success of the IKC Proof of Concept Awards

A total of 26 applications have been reviewed for the Innovation and Knowledge Centre (IKC) Industry Partnered Proof of Concept (PoC) Awards in Regenerative Medical Devices and Medical Devices with Enhanced Regenerative Functions. The awards scheme, launched in September 2016, was open to all institutions eligible to Research Council funding, with the aim of accelerating […]

Read More
Science and Innovation Audit published – Medical Technologies in the Leeds City Region

Science and Innovation Audit published – Medical Technologies in the Leeds City Region

Government, industry and the NHS needs to invest between £200 million and £250 million in the Leeds City Region’s medical technology sector over the next five years, to enable it to exploit opportunities in the global health market – according to a new Science and Innovation audit.

Read More

Tissue Regenix acquires CellRight Technologies

CellRight Technologies, a US-based producer of regenerative osteoinductive bone scaffolds, has been acquired by Tissue Regenix Group plc (TRG). The deal was finalised on 9 August 2017. CellRight, brings a complementary regenerative technology to TRG which can be applied to allograft bone, following a process that removes DNA from tissue, so that malleable applications such […]

Read More

Growth in Vericel’s autologous cell therapy products reported

Vericel’s commercial product line consists of MACI (autologous cultured chondrocytes on porcine collagen membrane) for the repair of symptomatic, full-thickness cartilage defects of the knee in adults; Carticel (expanded autologous chondrocytes for the repair of articular cartilage injuries in patients with inadequate responses to prior arthroscopic or other surgical procedures) and Epicel (sheets of a […]

Read More
back to top